In Conversation

“ ... Germany and the UK are the next strategic targets, but in those markets we will focus first on innovation. ”
“ ... Andalusia’s hospitals have never been fully saturated throughout the entire pandemic, which has allowed us to be supportive of other regions, sending ventilators and receiving… ”
“ Italy has a key role to play in the EU objective of guaranteeing continuity of supply during emergencies. ”
“ My dream is that Italy, thanks to its infrastructure and location, can become the leading pharma manufacturing logistics hub for the Mediterranean region, joining northern Africa… ”
“ The first approval of a regenerative medicine product in Korea was in 2002. Since then, a total of 15 cell and gene therapies, including immunotherapies and… ”
“ While Organon’s portfolio is meeting the needs of women, it is not enough. Governments and policymakers realise that they need to have tangible projects and approaches… ”
“ Accord recognises biosimilars as a future growth driver for the company. It is common sense as medicine moves to biologics and biologics move toward gene and… ”
“ I hope that the cooperation between packaging producers and pharmaceutical companies continues, especially in terms of co-development activity. Work is needed to improve access to these… ”
“ Brain health is not easy science because of the lack of biomarkers. However, with the right team, which I am convinced we have, a company of… ”
“ We truly believe that our R&D expertise, partnership appeal and focused go-to-market model make a recipe for success ”
“ The positive side of COVID is that it helped accelerate the transformation of healthcare systems into ones with greater agility ”
“ [We] are trying to build a global/local mix of expertise to encourage greater numbers of trials to be placed in Saudi Arabia moving forward, which is… ”
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here